Investor Relations Captor Therapeutics ®
Content of resolutions adopted by the Extraordinary General Meeting
Publication date:
Publication time:
Current report no. 7/2026
Date of preparation: 2 March 2026
Subject: Content of resolutions adopted by the Extraordinary General Meeting
Legal basis: Article 56(1)(2) of the Act on Offering - current and periodic information
The Management Board of Captor Therapeutics S.A., with its registered office in Wrocław (the “Company”), hereby provides the contents of the resolutions adopted by the Extraordinary General Meeting of the Company on 2 March 2026 (the “EGM”).
At the same time, the Company informs that the EGM did not waive consideration of any of the items on the planned agenda. There were no objections to the adopted resolutions.
Detailed legal basis:
§ 20 para. 1 pt. 6 of the Regulation of the Minister of Finance of 6 June 2025 on current and periodic information provided by issuers of securities and the conditions for recognising as equivalent the information required by the laws of a non-member state.